Innovaccer, a healthcare AI company, has secured $275 million in a Series F funding round, combining primary and secondary investments. The round included B Capital Group, Banner Health, Danaher Ventures, Kaiser Permanente, and M12. This new funding will help Innovaccer expand its AI-driven solutions for healthcare, enhance existing customer partnerships, and build a developer ecosystem on its platform. Founded in 2014, Innovaccer’s platform helps healthcare organizations reduce administrative burdens, modernize patient experiences, and support value-based care. The company’s AI and cloud-based tools cover a range of services, including utilization management, clinical decision support, care management, and contact centers. Innovaccer plans to roll out additional AI-powered agents and copilots across these areas. The company’s platform has seen significant adoption, now supporting over 130 healthcare organizations, including six of the top 10 U.S. health systems.
Innovaccer has experienced 50% annual revenue growth for the past five years, reflecting its growing market share in population health and data management. Abhinav Shashank, Co-Founder and CEO of Innovaccer, emphasized the company’s commitment to making healthcare more proactive and personalized. With this new investment, Innovaccer aims to expand its impact on healthcare delivery through AI and data-driven insights. Julie Sawyer Montgomery, EVP at Danaher, highlighted how Innovaccer’s AI solutions align with Danaher’s vision for enhancing clinical insights and accelerating the transition to personalized care. Innovaccer’s recent acquisitions of Cured and Pharmacy Quality Solutions further solidify its position in the market. To date, Innovaccer has raised $675 million from top venture firms and strategic investors, reinforcing its role in transforming healthcare through innovative technology.
